Clinical Trials with New Drugs
The cause of endometriosis remains unknown and because of this, there is no treatment available that will cure this disease. Over the years, the pharmaceutical industry has developed a variety of compounds in an attempt to control the disease and its symptoms. The Endometriosis Institute has participated in numerous clinical trials with these drugs. In the 1960s and 1970s, we evaluated danazol, the 1st effective medical treatment for endometriosis. In the 1980s and 1990s, we participated in clinical trials using different GnRH agonists. From the beginning of 2000, we studied different GnRH antagonists. Currently we are participating in clinical trials with compounds that selectively block estradiol beta receptor. We anticipate that in the near future we will be studying the effectiveness of drugs that selectively inhibit inflammatory cytokines.
Current Clinical Trials
We continue to perform basic and clinical research to identify the cause of Endometriosis, to develop non-invasive diagnostic tests and better treatment methods.